Valion Bio, Inc.

US$0.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VBIOHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (92.20%)
Div yield —
ROE (459.52%)
Biotechnology
Beta (5Y) 1.91
PE TTM —
TSR TTM (99.19%)
Mkt cap US$0.453M
ROIC (83.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.512
0.39%
(24.31%)
Hold 1|6|8|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
5.89%
2.81%
3.02%
(4.44%)
Revenue$M
0.036
0.038
0.040
0.039
1.68%
6.69%
15.59%
11.78%
Peers (US$0.453M)
Cap (US$)
PE
0.915M
—
0.857M
—
Capital
TTM
5Y
10Y
Leveragex
0.145
0.184
0.181
EBIT/Intx
0.993
0.336
0.220
Own earn%
101.98
(28.79)
(53.89)
Sh yield%
19.68
28.45
29.18
Owners
Insiders/Inst%
4.82
65.51
Short interest%
4.16
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
24–30
$1 testx
−0.1
Incr. ROIC%
7